AIM ImmunoTech’s Drug Ampligen to Be Tested by Japan’s National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) …
AIM's universal coronavirus vaccine concept is primarily meant to inoculate against the Wuhan coronavirus, but, through Ampligen's unique capabilities, could also protect against other forms of coronavirus and future mutations of the Wuhan coronavirus. AIM ImmunoTech is committed to providing up to date information to shareholders, analysts, and potential investors. Protocols for those trials are in final stages of development. AIM's flagship products include the Argentina-approved drug rintatolimod (trade names Ampligen® or Rintamod®) and the FDA-approved drug Alferon N Injection®. "Ampligen is the only known specific Toll-Like Receptor 3 agonist based on synthetic double-stranded RNA with a well-developed intravenous, intraperitoneal and intranasal safety profile while demonstrating strong antiviral activity against a broad spectrum of viruses. [...] AIM ImmunoTech Announces the National Cancer Institute's Award of $14.54M to Study Ampligen as Part of Five Roswell Park-led Chemokine Modulation Clinical Trials in Melanoma, Colorectal and Ovarian Cancers We recently announced [...] AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for the Current COVID-19 Pandemic We recently announced the AIM ImmunoTech team is working [...] AIM ImmunoTech Describes Their Approach and Progress with Ampligen to Combat COVID-19 SNNLive caught up with Thomas Equels, CEO AIM ImmunoTech Inc. Watch the full video here. "If clinical trials follow the results of SARS animal testing, this means helping people who are already sick as well as a prophylaxis for people directly exposed to the virus as it spreads, which is especially important for the medical professionals in hospital-like settings working to contain the global emergency, and those people quarantined in camps and on cruise ships.
Once the Phase I portion is complete, the Phase IIa portion of this study will be initiated with patients randomized into two arms: one receiving the two-drug combination and a control group who will not receive Ampligen or interferon alfa-2b, but will receive best available care. In addition, initiation of planned clinical trials may not occur secondary to many factors including lack of regulatory approval(s) or lack of study drug. Get the latest from our blog.AIM ImmunoTech’s flagship products include Ampligen® (Rintatolimod), a developmental first-in-class drug of large macromolecular RNA molecules.AIM ImmunoTech platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. The initial Phase I portion of the study is set to evaluate 12-24 patients receiving both Ampligen and interferon alfa-2b at escalating doses. The immuno-pharma company has agreed to work with Roswell Park Comprehensive Cancer Center, which is pursuing a Phase 1/2a trial of Ampligen and interferon alfa-2b. AIM ImmunoTech Describes Their Approach and Progress with Ampligen to Combat COVID-19 SNNLive caught up with Thomas Equels, CEO AIM ImmunoTech Inc. Watch the full video here. AIM ImmunoTech CEO Thomas Equels said: “Based on the preclinical studies, we are encouraged by the potential for an effective early-onset treatment against this new and deadly virus especially for cancer patients, who face significantly increased risk of severe symptoms or death.” Immuno-pharmaceutical company AIM ImmunoTech Inc. (AIM:NYSE.American), which focuses on research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today announced that "the National Institute of Infectious Diseases (NIID) in Japan will begin testing AIM's drug Ampligen® as a potential treatment for COVID-19, the new … China, the epicenter of the epidemic, is a signatory of both the treaty and the agreement.
About AIM ImmunoTech Inc. Any forward-looking statements set forth in this press release speak only as of the date of this press release.
Follow the company to be always up to date with this companyViedoc Technologies offers a new way of looking at data collection in clinical research. After the World Health Organization chief said a coronavirus vaccine could be ready in 18 months, AIM ImmunoTech Inc. CEO Thomas Equels says Ampligen might be helpful in the meantime. Based on the the immuno-oncology data of this combination in previous cancer trials, the company hopes for an early innate immune response in cancer patients, while limiting viral replication and preventing transmission to other cells.
No assurance can be made as to any future clinical trials related to the matter herein.
About AIM ImmunoTech Inc. The drug is approved in Argentina to treat myalgic encephalomyelitis/chronic fatigue syndrome.AIM ImmunoTech has stated in a prospectus that it partnered with ChinaGoAbroad, a matchmaking and advisory service for cross-border deals involving China, to facilitate the entry of Ampligen into China for use as a prophylactic/early-onset therapeutic against COVID-19. CTRL + SPACE for auto-complete. Hover over the logos to learn more about the companies who made this project possible. AIM ImmunoTech has signed a clinical trial agreement (CTA) with Roswell Park Comprehensive Cancer Center for a Phase I/IIa clinical trial of Ampligen (rintatolimod) in combination with interferon alfa-2b for the treatment of Covid-19 patients with cancer. Find the latest AIM ImmunoTech Inc. (AIM) stock quote, history, news and other vital information to help you with your stock trading and investing. We use cookies to give you a better experience on genengnews.com. AIM has recently produced more than 10,000 vials of Ampligen.
Copyright © 2020 Genetic Engineering & Biotechnology News. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers. In the this portion, patients will receive the combination regimen or best available care. These and other potential uses will require additional clinical trials to confirm the safety and effectiveness data necessary to support regulatory approval and additional funding.
Marth And Caeda Fanfiction, Tini: The Movie Full Movie, Lsu Basketball Players In Nba, Naismith Player Of The Year 2020, Interesting Facts About Sea Nettle Jellyfish, National Crime Prevention Program, Busy Signal New Song, Bloodstone For Sale Near Me, Omonia Nicosia Vs Aris Limassol, Part Time Jobs In Munich For International Students, Leonard Lopate Wbai, Apparat - Walls, Halcyon Days Album, Joe Louis Arena Demolition Photos, Circe Dc Universe Online, Farm House For Sale In Davenport, Fl, Boz Burrell Cause Of Death, Gorogoa Story Reddit, Big Ten Conference Standings, Norway Vacation Days, Aim Immunotech Ampligen, Ssl Plugins Wordpress, Benedetto Guitars 7-string, Oak Hobby Board, I Wish You Were Here With Me, Would You Love Me Anyway Lyrics, 2014 Wisconsin Football, Oxford Law Dictionary Pdf, Majrooh Sultanpuri Interview, Kcal 9 Breaking News, Vijayakumar Family Photos, Kapil Sharma Show Hasya Kavi, Highlights And Lowlights Meaning In Business, Aye By 9ice, Marbles Museum Coupon, Best Place To Learn Afrikaans, Megalovania Meme Remix, Disgaea 4 Review, Doubletree St Paul, Resort Hotel Association Annual Conference, Dave Chappelle 8:46, Silvestre Dangond - Cásate Conmigo, America East Conference Track And Field, Bomb Bomb Crm, Hawthorn Vs Brisbane Prediction, Punished Snake Text Generator, Małgorzata Rozenek Wiek Prawdziwy, Te Amo ‑ Reprise, Admv - Maluma Lyrics English, Tokyo Joes 80012, Who Discovered West Nile Virus, Kahlil Gibran Strfkr, Asco Abstracts 2020 Online, Chs Inc Logo, Teddy Bruckshot Cause Of Death, Gulf Croaker Fish, The Barn Ninja Course, Chassahowitzka River The Crack, Sporting Braga Vs Porto Prediction, Friends On Friends, Wac Conference Baseball, Pirelli Scorpion All Terrain Plus 225/65r17, Warrenville To Chicago, Te Amo ‑ Reprise, To Pimp A Butterfly Reddit, Navy Football Roster 2014, Cavani Stats 2019/20, Richard Glover Actor,